Viewing Study NCT00413166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-02-06 @ 12:50 PM
Study NCT ID: NCT00413166
Status: COMPLETED
Last Update Posted: 2019-05-07
First Post: 2006-12-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: All-trans Retinoic Acid, and Arsenic +/- Idarubicin
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Promyelocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Promyelocytic Leukemia View
None APL View
None ATRA View
None All-Trans Retinoic Acid View
None Arsenic Trioxide View
None Theophylline View
None Gemtuzumab View